166 related articles for article (PubMed ID: 9445303)
1. 5-Lipoxygenase and 5-lipoxygenase activating protein (FLAP) immunoreactivity in lungs from patients with primary pulmonary hypertension.
Wright L; Tuder RM; Wang J; Cool CD; Lepley RA; Voelkel NF
Am J Respir Crit Care Med; 1998 Jan; 157(1):219-29. PubMed ID: 9445303
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats.
Voelkel NF; Tuder RM; Wade K; Höper M; Lepley RA; Goulet JL; Koller BH; Fitzpatrick F
J Clin Invest; 1996 Jun; 97(11):2491-8. PubMed ID: 8647941
[TBL] [Abstract][Full Text] [Related]
3. In situ amplification of 5-lipoxygenase and 5-lipoxygenase-activating protein in allergic airway inflammation and inhibition by leukotriene blockade.
Chu SJ; Tang LO; Watney E; Chi EY; Henderson WR
J Immunol; 2000 Oct; 165(8):4640-8. PubMed ID: 11035107
[TBL] [Abstract][Full Text] [Related]
4. Alveolar lining fluid regulates mononuclear phagocyte 5-lipoxygenase metabolism.
Phare SM; Peters-Golden M; Coffey MJ
Eur Respir J; 1998 Nov; 12(5):1141-6. PubMed ID: 9864011
[TBL] [Abstract][Full Text] [Related]
5. 5-Lipoxygenase metabolism in alveolar macrophages from subjects infected with the human immunodeficiency virus.
Coffey MJ; Phare SM; Kazanjian PH; Peters-Golden M
J Immunol; 1996 Jul; 157(1):393-9. PubMed ID: 8683143
[TBL] [Abstract][Full Text] [Related]
6. Hyperoxia increases protein mass of 5-lipoxygenase and its activating protein, flap, and leukotriene B(4) output in newborn rat lungs.
Hosford GE; Koyanagi KS; Leung WI; Olson DM
Exp Lung Res; 2002 Dec; 28(8):671-84. PubMed ID: 12490039
[TBL] [Abstract][Full Text] [Related]
7. 5-Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation.
Woods JW; Coffey MJ; Brock TG; Singer II; Peters-Golden M
J Clin Invest; 1995 May; 95(5):2035-46. PubMed ID: 7738170
[TBL] [Abstract][Full Text] [Related]
8. Increased 5-lipoxygenase activating protein in immune-mediated experimental nephritis.
Montero A; Uda S; Kelavkar U; Yoshimura A; Badr KF; Munger KA
J Nephrol; 2003; 16(5):682-90. PubMed ID: 14733414
[TBL] [Abstract][Full Text] [Related]
9. Expression of 5-lipoxygenase and 5-lipoxygenase activation protein in glomerulonephritis.
Rifai A; Sakai H; Yagame M
Kidney Int Suppl; 1993 Jan; 39():S95-9. PubMed ID: 8468935
[TBL] [Abstract][Full Text] [Related]
10. Increases in 5-lipoxygenase activating protein expression account for enhanced capacity for 5-lipoxygenase metabolism that accompanies differentiation of peripheral blood monocytes into alveolar macrophages.
Coffey MJ; Wilcoxen SE; Peters-Golden M
Am J Respir Cell Mol Biol; 1994 Aug; 11(2):153-8. PubMed ID: 8049076
[TBL] [Abstract][Full Text] [Related]
11. Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis.
Wilborn J; Bailie M; Coffey M; Burdick M; Strieter R; Peters-Golden M
J Clin Invest; 1996 Apr; 97(8):1827-36. PubMed ID: 8621765
[TBL] [Abstract][Full Text] [Related]
12. IL-5 increases expression of 5-lipoxygenase-activating protein and translocates 5-lipoxygenase to the nucleus in human blood eosinophils.
Cowburn AS; Holgate ST; Sampson AP
J Immunol; 1999 Jul; 163(1):456-65. PubMed ID: 10384149
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoids stimulate inflammatory 5-lipoxygenase gene expression and protein translocation in the brain.
Uz T; Dwivedi Y; Savani PD; Impagnatiello F; Pandey G; Manev H
J Neurochem; 1999 Aug; 73(2):693-9. PubMed ID: 10428066
[TBL] [Abstract][Full Text] [Related]
14. Expression of 5-lipoxygenase and 5-lipoxygenase-activating protein mRNAs in the peripheral blood leukocytes of asthmatics.
Koshino T; Takano S; Houjo T; Sano Y; Kudo K; Kihara H; Kitani S; Takaishi T; Hirai K; Ito K; Morita Y
Biochem Biophys Res Commun; 1998 Jun; 247(2):510-3. PubMed ID: 9642160
[TBL] [Abstract][Full Text] [Related]
15. Regulation of 5-lipoxygenase metabolism in mononuclear phagocytes by CD4 T lymphocytes.
Coffey MJ; Phare SM; Peters-Golden M; Huffnagle GB
Exp Lung Res; 1999; 25(7):617-29. PubMed ID: 10598321
[TBL] [Abstract][Full Text] [Related]
16. Translocation and leukotriene synthetic capacity of nuclear 5-lipoxygenase in rat basophilic leukemia cells and alveolar macrophages.
Brock TG; McNish RW; Peters-Golden M
J Biol Chem; 1995 Sep; 270(37):21652-8. PubMed ID: 7665580
[TBL] [Abstract][Full Text] [Related]
17. 5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes.
Woods JW; Evans JF; Ethier D; Scott S; Vickers PJ; Hearn L; Heibein JA; Charleson S; Singer II
J Exp Med; 1993 Dec; 178(6):1935-46. PubMed ID: 8245774
[TBL] [Abstract][Full Text] [Related]
18. Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis.
Tuder RM; Chacon M; Alger L; Wang J; Taraseviciene-Stewart L; Kasahara Y; Cool CD; Bishop AE; Geraci M; Semenza GL; Yacoub M; Polak JM; Voelkel NF
J Pathol; 2001 Oct; 195(3):367-74. PubMed ID: 11673836
[TBL] [Abstract][Full Text] [Related]
19. The shunt from the cyclooxygenase to lipoxygenase pathway in human osteoarthritic subchondral osteoblasts is linked with a variable expression of the 5-lipoxygenase-activating protein.
Maxis K; Delalandre A; Martel-Pelletier J; Pelletier JP; Duval N; Lajeunesse D
Arthritis Res Ther; 2006; 8(6):R181. PubMed ID: 17156456
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin converting enzyme expression in primary pulmonary hypertension.
Schuster DP; Crouch EC; Parks WC; Johnson T; Botney MD
Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1087-91. PubMed ID: 8887612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
